Boston Scientific Corp (WBO:BSXC)
€ 68.5 1 (1.48%) Market Cap: 100.27 Bil Enterprise Value: 108.32 Bil PE Ratio: 61.71 PB Ratio: 5.42 GF Score: 73/100

Boston Scientific Corp at Sanford C Bernstein Strategic Decisions Conference Transcript

May 27, 2020 / 12:00PM GMT
Release Date Price: €33 (+0.06%)
Lee Michael Hambright
Sanford C. Bernstein & Co., LLC., Research Division - Analyst

Great. Hello, everybody. I'm Lee Hambright, U.S. medical devices analyst at Bernstein. We are thrilled to host Mike Mahoney and Susie Lisa from Boston Scientific. These are certainly unusual times. I'd like to thank everybody for joining over video conference.

Just a couple of housekeeping items. First, in lieu of question cards in the room, you'll see a Pigeonhole link available on the left side of your screen where you can submit questions during the session. And then second, at the end of the session, you'll have access to a very short investor poll through Prosensus.

All right. Mike, thanks for joining. Before we jump into Q&A, maybe you can kick us off with a few opening remarks.

Michael F. Mahoney
Boston Scientific Corporation - Chairman, President & CEO

Good morning, Lee. Can you hear me okay? I hope.

Lee Michael Hambright
Sanford C. Bernstein & Co., LLC., Research Division - Analyst

I

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot